{"id":4147,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2013-09-25","marketCap":4.0801825523376465,"name":"Evoke Pharma Inc","phone":"18583451494","outstanding":8.600000381469727,"symbol":"EVOK","website":"https://evokepharma.com/","industry":"Pharmaceuticals"},"price":5.088275,"year":2024,"month":8,"day":2,"weekday":"Friday","title":"Historical Stock Splits and Corporate Actions of Evoke Pharma Inc","date":"2024-08-02","url":"/posts/2024/08/02/EVOK","content":[{"section":"June 7, 2013","text":"Evoke Pharma Inc completes its initial public offering (IPO)."},{"section":"November 19, 2013","text":"Evoke Pharma Inc's stock undergoes a 1-for-10 reverse stock split, reducing the number of outstanding shares and increasing the share price."},{"section":"April 2, 2014","text":"Evoke Pharma Inc announces a registered direct offering of its common stock."},{"section":"June 22, 2016","text":"Evoke Pharma Inc announces a reverse stock split of its common stock at a ratio of 1-for-5."},{"section":"March 12, 2018","text":"Evoke Pharma Inc announces a reverse stock split of its common stock at a ratio of 1-for-10."},{"section":"September 13, 2019","text":"Evoke Pharma Inc's proposed merger with privately-held Cosmo Pharmaceuticals NV is terminated."},{"section":"October 23, 2019","text":"Evoke Pharma Inc announces a reverse stock split of its common stock at a ratio of 1-for-10."},{"section":"December 3, 2019","text":"Evoke Pharma Inc receives a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for its Gimoti NDA."}],"tags":["CrossOver21","Long","Pharmaceuticals"],"news":[{"category":"company","date":1722477360,"headline":"Evoke PLC Announces Total Voting Rights","id":129091118,"image":"","symbol":"EVOK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3580780685"},{"category":"company","date":1722408600,"headline":"Evoke Pharma trading halted, news pending","id":129050428,"image":"","symbol":"EVOK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3580208672"},{"category":"company","date":1722342600,"headline":"Evoke Pharma, Inc. Announces Reverse Stock Split","id":129003666,"image":"https://media.zenfs.com/en/globenewswire.com/913dba22981437221fb77be595cb1b09","symbol":"EVOK","publisher":"Yahoo","summary":"SOLANA BEACH, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTIÂ® (metoclopramide) nasal spray, today announced that its board of directors (Board) has approved a 1-for-12 reverse stock split of the company's common stock. The reverse stock split will become effective at 12:01 a.m. Eastern time on August 1, 2024. The company's common stock is","url":"https://finance.yahoo.com/news/evoke-pharma-inc-announces-reverse-123000596.html"},{"category":"company","date":1722325800,"headline":"Evoke Pharma announces 1-for-12 reverse stock split","id":129008145,"image":"","symbol":"EVOK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3577571216"},{"category":"company","date":1721710260,"headline":"LONDON BROKER RATINGS: UBS raises L\u0026G; RBC likes Ricardo","id":128855960,"image":"","symbol":"EVOK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=0amsfmsn4v"},{"category":"company","date":1721367780,"headline":"SMALL-CAP WINNERS \u0026 LOSERS: Evoke stays downbeat on guidance shift","id":128801805,"image":"","symbol":"EVOK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=bvimz98oun"}]}